Peel Therapeutics

Peel Therapeutics is a pioneering biotechnology research company dedicated to unlocking the potential of evolutionary biology to develop groundbreaking treatments for cancer and inflammatory diseases. By translating nature's most remarkable health outcomes, Peel Therapeutics is committed to creating innovative medicines that address critical medical needs.

Using cutting-edge technology, scientific expertise, and a deep understanding of drug development, Peel Therapeutics transforms nature's offerings into effective medicines. The company focuses on overcoming challenges related to solubility, scalability, and bioavailability, ensuring that its therapies can reach patients in need. Peel Therapeutics' clinical-stage therapeutic pipeline targets a wide range of devastating conditions, with a focus on cancer and inflammation. The primary address of Peel Therapeutics is 630 South Komas Drive, Suite 300, Salt Lake City, Utah 84108, US, and another address is HaHaroshet Street 5, Nesher, Haifa District 3688105, IL.

Peel Therapeutics pushes the boundaries of biology to develop highly effective and safe medicines that go beyond incremental improvements. The company is dedicated to providing patients with transformative therapies that improve their lives. Peel Therapeutics is poised to make significant advancements in the treatment of cancer and inflammatory diseases. Company information will be completed soon with the support of the company’s management.

We invite the manager of Peel Therapeutics to create a customized and exclusive company showcase and product listing on our platform.